United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 26, 2020 | Director | 5,000 | $91.75 | Sell | $458,750.00 | |
June 27, 2019 | Director | 3,750 | $76.11 | Sell | $285,412.50 | |
June 20, 2019 | Director | 5,000 | $79.05 | Sell | $395,250.00 | |
March 7, 2019 | Director | 3,370 | $110.75 | Sell | $373,227.50 | |
Feb. 5, 2019 | Director | 400 | $117.00 | Sell | $46,800.00 | |
Jan. 30, 2019 | CEO | 14,108 | $115.77 | Sell | $1,633,283.16 | |
Jan. 28, 2019 | CEO | 14,108 | $115.37 | Sell | $1,627,639.96 | |
Jan. 24, 2019 | CEO | 7,054 | $113.95 | Sell | $803,803.30 | |
Jan. 22, 2019 | CEO | 7,054 | $113.35 | Sell | $799,570.90 | |
Jan. 17, 2019 | CEO | 14,108 | $113.70 | Sell | $1,604,079.60 | |
Jan. 15, 2019 | CEO | 14,108 | $114.85 | Sell | $1,620,303.80 | |
Jan. 10, 2019 | CEO | 14,108 | $113.51 | Sell | $1,601,399.08 | |
Jan. 8, 2019 | CEO | 7,054 | $113.16 | Sell | $798,230.64 | |
Jan. 4, 2019 | CEO | 7,055 | $111.51 | Sell | $786,703.05 | |
Sept. 10, 2018 | Director | 810 | $119.00 | Sell | $96,390.00 | |
Sept. 6, 2018 | Director | 810 | $118.00 | Sell | $95,580.00 | |
Aug. 16, 2018 | Director | 3,240 | $129.38 | Sell | $419,191.20 | |
Aug. 3, 2018 | Director | 580 | $127.48 | Sell | $73,938.40 | |
June 29, 2018 | Director | 3,240 | $113.07 | Sell | $366,346.80 | |
June 12, 2018 | Director | 600 | $112.38 | Sell | $67,428.00 | |
April 9, 2018 | CEO | 21,513 | $110.88 | Sell | $2,385,361.44 | |
April 5, 2018 | CEO | 21,512 | $114.30 | Sell | $2,458,821.60 | |
April 3, 2018 | CEO | 22,059 | $114.44 | Sell | $2,524,431.96 | |
March 29, 2018 | CEO | 43,024 | $111.14 | Sell | $4,781,687.36 | |
March 22, 2018 | CEO | 1,100 | $110.01 | Sell | $121,011.00 | |
March 20, 2018 | CEO | 301 | $110.48 | Sell | $33,254.48 | |
March 16, 2018 | CEO | 43,025 | $111.11 | Sell | $4,780,507.75 | |
March 14, 2018 | CEO | 21,512 | $112.55 | Sell | $2,421,175.60 | |
Dec. 8, 2017 | CEO | 1 | $136.16 | Sell | $136.16 | |
Dec. 7, 2017 | Director | 580 | $134.72 | Sell | $78,137.60 | |
Nov. 30, 2017 | CEO | 1,241 | $128.95 | Sell | $160,026.95 | |
Nov. 24, 2017 | CEO | 1,253 | $124.07 | Sell | $155,459.71 | |
Nov. 16, 2017 | CEO | 7,061 | $121.12 | Sell | $855,228.32 | |
Nov. 9, 2017 | CEO | 1,260 | $121.46 | Sell | $153,039.60 | |
Nov. 6, 2017 | Director | 580 | $122.00 | Sell | $70,760.00 | |
Nov. 2, 2017 | CEO | 1,269 | $118.04 | Sell | $149,792.76 | |
Oct. 26, 2017 | CEO | 1,263 | $120.38 | Sell | $152,039.94 | |
Oct. 19, 2017 | CEO | 1,265 | $119.38 | Sell | $151,015.70 | |
Oct. 12, 2017 | CEO | 1,263 | $120.20 | Sell | $151,812.60 | |
Oct. 5, 2017 | CEO | 1,256 | $122.98 | Sell | $154,462.88 | |
Oct. 5, 2017 | Director | 580 | $122.00 | Sell | $70,760.00 | |
Sept. 28, 2017 | CEO | 1,265 | $119.70 | Sell | $151,420.50 | |
Sept. 21, 2017 | CEO | 1,274 | $116.07 | Sell | $147,873.18 | |
Sept. 14, 2017 | CEO | 1,258 | $122.08 | Sell | $153,576.64 | |
Sept. 7, 2017 | CEO | 1,232 | $133.32 | Sell | $164,250.24 | |
Sept. 7, 2017 | Director | 580 | $134.48 | Sell | $77,998.40 | |
Aug. 31, 2017 | CEO | 1,235 | $130.49 | Sell | $161,155.15 | |
Aug. 24, 2017 | CEO | 1,238 | $130.65 | Sell | $161,744.70 | |
Aug. 17, 2017 | CEO | 1,235 | $131.95 | Sell | $162,958.25 | |
Aug. 10, 2017 | CEO | 2,176 | $127.11 | Sell | $276,591.36 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.